Does Topical Steroid Treatment Impair the Adrenal Function?
|ClinicalTrials.gov Identifier: NCT00476489|
Recruitment Status : Unknown
Verified May 2007 by HaEmek Medical Center, Israel.
Recruitment status was: Recruiting
First Posted : May 22, 2007
Last Update Posted : May 22, 2007
|Condition or disease|
|Hypothalamus-Pituitary-Adrenal Axis Assessement Topical Steroid Therapy in Chronic Skin Diseases|
Adrenocortical suppression is a potential complication of systemic corticosteroid treatement but also of non systemic therapy like topical therapy.
The normalcy of hypothalamic-pituitary-adrenal axis ( HPA axis) of patients with chronic skin diseases like atopic dermatitis, pemphigus or psoriasis which are treated with topical steroids, will be assessed with the low dose (1mcg) adrenocortocotropin ( ACTH) stimulation test. During this test serum cortisol levels are measured before, 30 and 60 mn after intravenous administration of 1mcg of ACTH (synacthen).The results will be compared with age and sex matched subjects with normal HPA axis as assessed by low dose ACTH stimulation test.
|Study Type :||Observational|
|Estimated Enrollment :||50 participants|
|Observational Model:||Case Control|
|Official Title:||Low Dose (1mcg) ACTH Stimulation Test for Assessment of the Hypothalamo-Pituitary- Adrenal Axis in Patients Treated With Topical Corticosteroids|
|Study Start Date :||May 2007|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00476489
|Contact: Avraham Ishay, MDfirstname.lastname@example.org|
|Contact: Rafael Luboshitzky, MDemail@example.com|
|Haemek Medical Center||Recruiting|
|Afula, Israel, 18101|
|Contact: Avraham Ishay, MD 972-4-6495556 firstname.lastname@example.org|
|Principal Investigator:||Avraham Ishay, MD||haemek medical center|